Riskpilot← Back to searchSign inGet full accessEva-Maria Oxblom AB
ABActiveOrg 5564127032Haspelvägen 22Medical specialists activities · NACE 8622Est. 19900 employees
Revenue 2025
SEK 1,3M
+139% vs 2024
EBITDA margin
67.6%
+152% vs 2024
Equity ratio
32.5%
Financial strength
Net profit 2025
SEK 687K
+152% vs 2024
| Revenue | SEK 1,3M | +139% |
| EBITDA | SEK 866K | +152% |
| Net profit | SEK 687K | +152% |
| Total assets | SEK 394K | -6% |
| Equity | SEK 128K | +2% |
| Employees | 0 | — |
Legal name
Eva-Maria Oxblom AB
Org number
5564127032
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
27 november 1990
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva medicinsk hälsovård, konsultverksamhet för såväl slutenvård som öppenvård, medicinsk teknik, och äga, förvalta och investera i värdepapper såsom aktier och fonder samt därmed förenlig verksamhet.
Address
Haspelvägen 22
Phone
+46705945115
Email
alexanderoxblom@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 356 | 605 | 821 | 537 | 1 281 |
| Staff expenses | — | −24 | −72 | −4 | −41 |
| EBITDA | 312 | 490 | 679 | 343 | 866 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 312 | 490 | 679 | 343 | 866 |
| Net financials | 18 | −1 | −1 | −0 | −1 |
| Profit before tax | 330 | 488 | 678 | 343 | 865 |
| Tax | −71 | −101 | −140 | −71 | −178 |
| Net profit | 259 | 388 | 538 | 272 | 687 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 477 | 496 | 769 | 421 | 394 |
| Equity | 297 | 240 | 453 | 125 | 128 |
| Long-term debt | 17 | 11 | 0 | 99 | 1 |
| Short-term debt | 197 | 245 | 316 | 197 | 265 |
| Total debt | 214 | 256 | 316 | 296 | 266 |
EBITDA margin
67.6%
This company
15.8%
Market median
+328% vs market
20212025
Equity ratio
32.5%
This company
38.2%
Market median
+15% vs market
20212025
Return on equity
536.3%
This company
18.4%
Market median
+2815% vs market
20212025
Net profit margin
53.6%
This company
8.1%
Market median
+562% vs market
20212025
Asset turnover
3.25×
This company
1.12×
Market median
+190% vs market
20212025
Debt / equity
2.08×
This company
0.62×
Market median
-235% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Eva-Maria Oxblom AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Maria Oxblom | Chairman | 0 companies |
| Alexander Philip Oxblom | Board of Directors | 0 companies |
| Bartosz Zbigniew Motyczynski | Deputy Board Member | 0 companies |